Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Sensors (Basel, Switzerland)|April 30, 2021
Gas Damping in Capacitive MEMS Transducers in the Free Molecular Flow RegimeBoris A Boom, Alessandro Bertolini, Eric Hennes, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2003
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factorSilvia Ferrari, Bianca Rovati, Camillo Porta, et al.
Tumori|March 15, 2008
Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancerAntonio Ardizzoia, Ilaria Colombo, Monica Giordano, et al.
Anticancer Research|May 7, 2017
EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung CancerFilippo DE Marinis, Paolo Bidoli, Andrea Luciani, et al.
Life (Basel, Switzerland)|March 27, 2025
Optimizing Lung Cancer Diagnostics: Insights from a Fast-Track Program in a Complex Healthcare SettingPaolo Scanagatta, Alessandro Bertolini, Giuseppe Naldi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2015
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II studyMaria Di Bartolomeo, Andrea Ciarlo, Alessandro Bertolini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 25, 2010
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trialLuigi Celio, Sergio Frustaci, Angela Denaro, et al.
Tumori|April 4, 2013
Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based surveyDiego Cortinovis, Giordano Beretta, Elena Piazza, et al.
Tumori|October 25, 2014
Granulocyte colony-stimulating factors used in clinical practice: PoloNord Registry-Based Cohort Italian StudyDaniele Fagnani, Luciano Isa, Magda Franca Verga, et al.
World Journal of Gastroenterology|June 26, 2015
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX studyLorenzo Antonuzzo, Elisa Giommoni, Davide Pastorelli, et al.
Pageof 3